Altana Pharma/Nycomed
About Altana Pharma/Nycomed
"Takeda es una compañía biofarmacéutica líder a nivel internacional basada en valores e impulsada por su actividad en I+D. Takeda tiene su sede central en Japón y está fuertemente comprometida con una mejor salud y un futuro mejor para los pacientes, traduciendo la ciencia en medicamentos altamente innovadores. Takeda centra sus esfuerzos de I+D en cuatro áreas terapéuticas: oncología, enfermedades raras, neurociencias y gastroenterología. También realiza inversiones de I+D específicas en terapias derivadas de plasma y vacunas."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Altana Pharma/Nycomed
During the past decade, Altana Pharma/Nycomed conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Botox Injection for Lower Extremity Lengthening and Deformity Correction Surgery
2007-01-01
2012-12-01
Completed
125
Bracing in Adolescent Idiopathic Scoliosis Trial (BrAIST)
2007-02-01
2013-09-01
Terminated
383
The Effect of Locomotor Training on Children With Incomplete Spinal Cord Injuries
2009-03-01
Withdrawn
0
An Efficacy and Safety Trial of Intravenous Zoledronic Acid in Infants Less Than One Year of Age, With Severe Osteogenesis Imperfecta
2007-10-01
2016-04-01
Completed
14
A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia
2011-04-01
2013-10-01
Completed
29
An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
2012-02-01
2014-06-01
Completed
23
Steroid-Induced Osteoporosis in the Pediatric Population - Canadian Incidence Study
2005-01-01
2014-03-06
Completed
406
Effect of High-Dose Vitamin D on Bone Density in Osteogenesis Imperfecta
2012-09-01
2014-07-01
Completed
60
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Altana Pharma/Nycomed"
#1 collaborator was "Nycomed GmbH" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Altana Pharma/Nycomed
According to Clinical.Site data, the most researched conditions in "Altana Pharma/Nycomed" are
"Asthma" (4 trials), "Gastroesophageal Reflux Disease (GERD)" (1 trials) and "Pneumonia" (1 trials). Many other conditions were trialed in "Altana Pharma/Nycomed" in a lesser frequency.
Clinical Trials Intervention Types at Altana Pharma/Nycomed
Most popular intervention types in "Altana Pharma/Nycomed" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Ciclesonide" (4 trials), "Placebo" (2 trials), "Pantoprazole" (1 trials), "Salbutamol" (1 trials) and "Venticute" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Altana Pharma/Nycomed
The vast majority of trials in "Altana Pharma/Nycomed" are
6 trials for "All" genders.
Clinical Trials Status at Altana Pharma/Nycomed
Currently, there are NaN active trials in "Altana Pharma/Nycomed".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Altana Pharma/Nycomed,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Altana Pharma/Nycomed, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".